Skip to content
Announcement:
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics for Metabolic Diseases
Announcement:
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Blog Post:
Engineering CAR T-Cells to Function Where Others Fail
Generative Biology®
The Generate Platform™
Pipeline
About Us
Careers
Media Center
Investors
Menu
Close
Generative Biology®
The Generate Platform™
Pipeline
About Us
Careers
Media Center
Investors
LinkedIn
X
YouTube
Presentations & Publications
ERS 2025: ePoster
09.28.2025
Download as PDF
